Daptomycin use: where is the truth?

Future Microbiol. 2017 Jan:12:9-12. doi: 10.2217/fmb-2016-0142. Epub 2016 Dec 12.

Guillaume Ghislain Aubin^{1

2}, Colin Deschanvres³, David Boutoille^{2

3}, Pierre Abgueguen⁴, Stéphane Corvec¹, Jocelyne Caillon^{1

2}, Didier Lepelletier^{1

5}, Frédéric Moal⁶, Dominique Navas^{2

7}

¹ Department of Bacteriology & Infection control, Nantes University Hospital, Nantes, France.
² EA3826, Laboratory of Clinical & Experimental Therapeutics of Infections, IRS2, 22 Bd Bénoni-Goullin, Nantes, France.
³ Infectious Diseases Department, Nantes University Hospital, Nantes, France.
⁴ Infectious Diseases Department, Angers University Hospital, Angers, France.
⁵ Microbiotas, Hosts, Antibiotics & Bacterial Resistances Lab, IRS2, 22 Bd Bénoni-Goullin, Nantes, France.
⁶ Pharmacy Department, Angers University Hospital, Angers, France.
⁷ Pharmacy Department, Nantes University Hospital, Nantes, France.

No abstract available

Keywords: Staphylococcus; antimicrobial stewardship; clinical impact; daptomycin use.

Publication types